| Reaction Details |
|---|
 | Report a problem with these data |
| Target | LIM domain kinase 1 |
|---|
| Ligand | BDBM622422 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | In Vitro Assay |
|---|
| Ki | 19.8±n/a nM |
|---|
| Citation |  ROUTIER, S; BENEDETTI, H; LÉE-MÉHEUST, B; BONNET, P; PLÉ, K; ACI-SÈCHE, S; RUCHAUD, S; BRAKA, A; CHAMPIRÉ, A; ANDRES, C; VOURC''H, P 4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-3,6-DIHYDROPYRIDINE-1-(2H)-CARBOXAMIDE DERIVATIVES AS LIMK AND/OR ROCK KINASES INHIBITORS FOR USE IN THE TREATMENT OF CANCER US Patent US20230312576 Publication Date 10/5/2023 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| LIM domain kinase 1 |
|---|
| Name: | LIM domain kinase 1 |
|---|
| Synonyms: | LIMK | LIMK-1 | LIMK1 | LIMK1_HUMAN |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 72591.81 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | gi_4505001 |
|---|
| Residue: | 647 |
|---|
| Sequence: | MRLTLLCCTWREERMGEEGSELPVCASCGQRIYDGQYLQALNADWHADCFRCCDCSASLS
HQYYEKDGQLFCKKDYWARYGESCHGCSEQITKGLVMVAGELKYHPECFICLTCGTFIGD
GDTYTLVEHSKLYCGHCYYQTVVTPVIEQILPDSPGSHLPHTVTLVSIPASSHGKRGLSV
SIDPPHGPPGCGTEHSHTVRVQGVDPGCMSPDVKNSIHVGDRILEINGTPIRNVPLDEID
LLIQETSRLLQLTLEHDPHDTLGHGLGPETSPLSSPAYTPSGEAGSSARQKPVLRSCSID
RSPGAGSLGSPASQRKDLGRSESLRVVCRPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRE
TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT
LRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFG
LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC
EIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL
EHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGESGLPAHPEVPD
|
|
|
|---|
| BDBM622422 |
|---|
| n/a |
|---|
| Name | BDBM622422 |
|---|
| Synonyms: | US20230312576, Compound 78 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C28H27N5O2 |
|---|
| Mol. Mass. | 465.5463 |
|---|
| SMILES | COc1ccc(cc1)-c1cccc(NC(=O)N2CCC(=CC2)c2ncnc3[nH]cc(C4CC4)c23)c1 |c:20| |
|---|
| Structure | 
|
|---|
Search and Browse
